AMH and cancer: This study showed that in this group of cancer survivors, ovarian reserve, as reflected by levels of antral follicle count, AMH, and menstrual regularity, could not discriminate the experience of menopausal symptoms during a follow-up of 1.1 up to 11.3 years [48].